IRIS - Res&Arch Institutional Research Information System - Research & Archive

FIORUCCI, Stefano
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 11.443
EU - Europa 8.930
AS - Asia 2.630
SA - Sud America 28
Continente sconosciuto - Info sul continente non disponibili 15
AF - Africa 11
OC - Oceania 7
Totale 23.064
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.338
IE - Irlanda 2.041
UA - Ucraina 2.001
SE - Svezia 1.438
IT - Italia 1.145
SG - Singapore 791
VN - Vietnam 623
FI - Finlandia 566
HK - Hong Kong 566
DE - Germania 539
RU - Federazione Russa 446
CN - Cina 331
GB - Regno Unito 224
FR - Francia 184
KR - Corea 120
TR - Turchia 117
CH - Svizzera 90
CA - Canada 86
AT - Austria 49
BE - Belgio 39
NL - Olanda 34
PL - Polonia 33
UZ - Uzbekistan 31
CZ - Repubblica Ceca 30
LB - Libano 25
GR - Grecia 23
RO - Romania 20
BR - Brasile 19
MX - Messico 19
EU - Europa 15
ES - Italia 8
AU - Australia 6
JP - Giappone 5
AE - Emirati Arabi Uniti 4
BG - Bulgaria 4
CI - Costa d'Avorio 4
TW - Taiwan 4
CO - Colombia 3
EG - Egitto 3
IN - India 3
PY - Paraguay 3
AL - Albania 2
BD - Bangladesh 2
CL - Cile 2
EE - Estonia 2
HR - Croazia 2
IR - Iran 2
LT - Lituania 2
RS - Serbia 2
AM - Armenia 1
AO - Angola 1
BO - Bolivia 1
CY - Cipro 1
DK - Danimarca 1
DZ - Algeria 1
GH - Ghana 1
HU - Ungheria 1
IQ - Iraq 1
KZ - Kazakistan 1
LU - Lussemburgo 1
MA - Marocco 1
ME - Montenegro 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PH - Filippine 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
Totale 23.064
Salva come PNG Salva come JPEG
Città #
Chandler 2.286
Dublin 2.032
San Mateo 1.227
Jacksonville 837
Boardman 743
Dong Ket 622
Hong Kong 566
Medford 547
Princeton 542
Altamura 518
Wilmington 497
Singapore 496
Lawrence 381
Andover 345
Ann Arbor 341
Des Moines 313
Perugia 235
Ashburn 171
Saint Petersburg 165
Beijing 143
Izmir 116
Norwalk 96
Falls Church 95
Helsinki 81
Ottawa 77
Woodbridge 64
Los Angeles 60
San Paolo di Civitate 57
Shanghai 49
Seoul 47
Brussels 39
Redwood City 35
New York 33
Redmond 33
Houston 30
Dallas 29
Moscow 27
Auburn Hills 25
Den Haag 25
Santa Clara 25
Dearborn 23
Munich 18
Timisoara 18
Chicago 14
Vienna 14
Lausanne 13
Olomouc 12
Tappahannock 12
Lappeenranta 11
Rome 10
Florence 9
Frankfurt Am Main 9
Naples 9
Philadelphia 9
Amsterdam 8
San Diego 8
Simi Valley 8
Seattle 7
Brugg 6
Kiev 6
London 6
Nanjing 6
Toronto 6
Verona 6
Bologna 5
Cambridge 5
Cuauhtémoc 5
Ludwigshafen 5
Lugano 5
Milan 5
Phoenix 5
Sydney 5
São Paulo 5
Tokyo 5
Abidjan 4
Al Ain City 4
Espoo 4
Fairfield 4
Fremont 4
Menlo Park 4
Napoli 4
Brno 3
Cairo 3
Catania 3
Edinburgh 3
Fernando De La Mora 3
Frankfurt am Main 3
Giugliano In Campania 3
Guangzhou 3
Hanover 3
Madrid 3
Mexico City 3
Prata Di Pordenone 3
Rovato 3
State College 3
Stockholm 3
Taranto 3
Terni 3
Zhengzhou 3
Arzano 2
Totale 14.432
Salva come PNG Salva come JPEG
Nome #
Recombinant galectin-1 prevents experimental colitis in mice via T cell apoptosis. 157
Il reflusso entero-gastrico:quale ruolo nella patogenesi dell' esofagite 133
An NO-derivative of acetaminophen, NCX-701, spares the liver by inhibiting Fas-dependent apoptosis 91
Efficacy of the CCR5 antagonist maraviroc in reducing early, ritonavir-induced atherogenesis and advanced plaque progression in mice. 86
Cancro gastrico localmente avanzato. Dati preliminari di studio di fase II di chemioterapia neoadiuvante, chirurgia radicale e chemioterapia adiuvante ad alte dosi con autotrapianto di cellule staminali da sangue periferico. 85
Bombesin-Induced Pancreatic Regeneration in pigs in associated with p46Shc/p52Shc and p42/p44 MAP kinase Phosphorilation 85
Activation of the farnesoid-X receptor protects against gastrointestinal injury caused by non-steroidal anti-inflammatory drugs in mice. 85
Anti-HIV Protease Inhibitors Interact With NSAIDs and Exacerbate Small Intestine Enteropathy Induced by NSAIDs 85
BAR502, a Dual FXR and GPBAR1 Agonist, Reverses Steatosis and Fibrosis in Rodent Model of NASH By Modulating Authophagic Genes 84
Isolated guinea pig gastric chief cells express tumor necrosis factor receptors coupled with the sphingomyelin pathway 83
Activation of the bile acid receptor GPBAR1 protects against gastrointestinal injury caused by non-steroidal anti-inflammatory drugs and aspirin in mice. 83
The bile acid receptor GPBAR1 regulates the M1/M2 phenotype of intestinal macrophages and activation of gpbar1 rescues mice from murine colitis 82
Aspirin-triggered, cyclooxygenase-2-dependent lipoxin synthesis modulates vascular tone. 80
The bile acid receptor GPBAR1 (TGR5) is expressed in human gastric cancers and promotes epithelial-mesenchymal transition in gastric cancer cell lines 80
A new protective mechanisn in NSAID gastropathy. Evidence that hydrogen sulfide (H2S) modulates gastric mucosal integrity 78
21-NO-prednisolone is a novel nitric oxide-releasing derivative of prednisolone with enhanced anti-inflammatory properties. 78
Anti-very late antigen-1 monoclonal antibody modulates the development of secondary lesion and T-cell response in experimental arthritis 78
PAR-2 modulates pepsinogen secretion from gastric-isolated chief cells. 77
Enhanced anti-inflammatory effects of a nitric oxide-releasing derivative of mesalamine in rats. 77
Effect of acute and chronic levosulpiride administration on gastric tone and perception in functional dyspepsia. 76
Bile-acid-activated farnesoid X receptor regulates hydrogen sulfide production and hepatic microcirculation. 76
Prostaglandin-e2 Desensitizes Camp-mediated Pepsinogen Secretion In Chief Cells 76
A magic bullet for mucosal protection...and aspirin is the trigger! 74
Nitric oxide regulates immune cell bioenergetic: a mechanism to understand immunomodulatory functions of nitric oxide-releasing anti-inflammatory drugs. 73
Cooperation between Aspirin-triggered lipoxin and nitric oxide (NO) mediates anti-adhesive properties of NCX-4016 (NO-aspirin) on neutrophil-endothelial cell adherence. 72
A nitro-arginine derivative of trimebutine (NO2-Arg-Trim) attenuates pain induced by colorectal distension in conscious rats. 72
NO-aspirin protects from T cell-mediated liver injury by inhibiting caspase-dependent processing of Th1-like cytokines 72
The aryl hydrocarbon receptor (AhR) mediates the counter-regulatory effects of pelargonidins in models of inflammation and metabolic dysfunctions 72
Bile acid-activated receptors in the treatment of dyslipidemia and related disorders. 71
BAR 501, a Novel GPBAR1 Ligand, Reverses Intestinal and Liver Inflammatory Models Demonstrating That GPBAR1 Is an Essential Modulator of Innate Immunity in Entero-Hepatic Tissues 71
Effect of bombesin on pancreatic regeneration after subtotal distal pancreasectomy. 70
Antiatherosclerotic effect of farnesoid X receptor. 70
Nitric oxide inhibits cathepsin B, UPA and plasmin activity via S-nitrosylation in vitro and in vivo. 70
NO-naproxen modulates inflammation, nociception and downregulates T cell response in rat Freund's adjuvant arthritis. Br J Pharmacol 69
3-oxa-lipoxin A4 analog treats colitis induced by Dss by attenuating inflammation and immunity. 69
Diethylstilbestrol-scaffold-based pregnane X receptor modulators 69
BAR501, A SELECTIVE GPBAR1 AGONIST, PROMOTES ADIPOSE TISSUE BROWNING AND AUTOPHAGY AND IMPROVES LIPID METABOLISM AND STEATO-HEPATITIS IN MICE FEED A HIGH FAT DIET 69
Essential counter-regulatory role of farnesoid-X-receptor (FXR) for intestinal innate immunity 68
Reciprocal regulation of the bile acid-activated receptor FXR and the interferon-gamma-STAT-1 pathway in macrophages. 68
Interleukin 18 restores defective Th1 immunity to Candida albicans in caspase 1-deficient mice. 68
A farnesoid X receptor-small heterodimer partner regulatory cascade modulates tissue metallproteinase inhibitor-1 and matrix metallprotease expression in hepatic stellate cells and promotes resolution of liver fibrosis’ 67
LESIONI FOCALI EPATICHE MALIGNE 67
PPARs and other nuclear receptors in inflammation. 67
Glucocorticoid receptor mediates the gluconeogenic activity of the farnesoid X receptor in the fasting condition 67
Endothelial nitric oxide synthase: the Cinderella of inflammation? 67
Nitric oxide-releasing NSAIDs: a review of their current status. 66
An essential role of Farnesoid X-Receptor in regulating intestinal fibrosis in murine model of chronic colitis 66
Pathogenesis of non-steroidal anti-inflammatory drug gastropathy. A Review. 65
Leukotrienes stimulate pepsinogen secretion from guinea pig gastric chief cells by a nitric oxide-dependent pathway 65
5-Amino-2-hydroxybenzoic acid 4-(5-thioxo-5H-[1,2]dithiol-3yl)-phenyl ester (ATB-429), a hydrogen sulfide-releasing derivative of mesalamine, exerts antinociceptive effects in a model of postinflammatory hypersensitivity. 65
Indomethacin modulates Mac-1 expression on circulating neutrophils by inducing Ca2+ mobilization and tyrosine kinase activation. 65
3alpha-6alpha-Dihydroxy-7alpha-fluoro-5beta-cholanoate (UPF-680), physicochemical and physiological properties of a new fluorinated bile acid that prevents 17alpha-ethynyl-estradiol-induced cholestasis in rats.. 64
NO-naproxen modulates inflammation, nociception and downregulates T cell response in rat Freund's adjuvant arthritis 64
Anatomia del fegato 64
NCX-1000, a NO-releasing derivative of ursodeoxycholic acid, selectively delivers NO to the liver and protects against development of portal hypertension 63
Administration of 3 alpha-6 alpha-dihydroxy-7a alpha-fluoro-5 beta-cholanoate (UPF-680) in chronic cholestasis induced by 17 alpha-ethynyl-estradiol (17 alpha EE) in rats. 63
Activation of FXR Improves Myocardial Fatty Acid Metabolism in a Rodent Model of Liver Steatosis 63
Barriera mucosa esofagea e meccanismi aggressivi. 63
Cyclo-oxygenase isoenzymes. Structural basis for selective inhibition of cyclo-oxygenases by anti-inflammatory agents 62
NO-aspirin: mechanism of action and gastrointestinal safety 62
Epidermal growth factor modulates pepsinogen secretion in guinea pig gastric chief cells 62
Preliminary structure-activity relationship on theonellasterol, a new chemotype of FXR antagonist, from the marine sponge Theonella swinhoei. 62
a Farnesoid-X-Receptor (FXR)-Glucocorticoid Receptor (GR) Cascade Regulates Intestinal Innate Immunity in Response to FXR Activation 61
A new nitric oxide steroid derivative (NCX 1015) with enhanced anti-inflammatory properties reduces colonic inflammation in mice. 61
Dissociation of intestinal and hepatic activities of FXR and LXRα supports metabolic effects of terminal ileum interposition in rodents. 61
Design, synthesis, and biological evaluation of potent dual agonists of nuclear and membrane bile acid receptors. 61
Interactions Between Nuclear Receptor SHP and FOXA1 Maintain Oscillatory Homocysteine Homeostasis in Mice 61
A Comprehensive Analysis of Small Heterodimer Partner (SHP) Target Genes in Hepatic Stellate Cells and the Discovery of a New Class of SHP Agonists That Reduces Liver Fibrosis 61
Hyperglycemia Inhibits the Erythromycin-induced Gallbladder Emptying In Normal Subjects 60
Atti VII convegno nazionale GISMAD 60
Antinfiammatori non steroidei 60
Agonism for the bile acid receptor GPBAR1 reverses liver and vascular damage in a mouse model of steatohepatitis 60
Inhibition of intestinal bacterial translocation with rifaximin modulates lamina propria monocytic cells reactivity and protects against inflammation in a rodent model of colitis. 59
Helicobacter pylori and non-steroidal anti-inflammatory drugs. 59
TNFalpha processing enzyme inhibitors prevent aspirin-induced TNFalpha release and protect against gastric mucosal injury in rats 59
NCX-1015, a nitric-oxide derivative of prednisolone, enhances regulatory T cells in the lamina propria and protects against 2,4,6-trinitrobenzene sulfonic acid-induced colitis in mice. 59
Cyclooxygenase-2-derived lipoxin A4 increases gastric resistance to aspirin-induced damage. 59
NSAID-induced TNF alpha release from macrophages is the key mediator of gastric mucosal injury. 59
BAR130, A HYODEOXYCHOLIC ACID DERIVATIVE AS THE FIRST EXAMPLE OF DUAL LXR alpha/GPBAR1 AGONIST 59
Identification of Cysteinyl-leukotriene-receptor 1 antagonists as ligands for the bile acid receptor GPBAR1 59
Analysis of Gastric Cancer Transcriptome Allows the Identification of Histotype Specific Molecular Signatures With Prognostic Potential 59
The Fanesoid-X-Receptor ligand INT-747 regulates organic transporters alpha and beta (Ost alpha and Ost beta) in liver cells and rodent model of cholestasis 58
5-hydroxytryptamine 3-receptor Antagonist Modulates Gallbladder Emptying and Motilin Release Induced By Erythromycin 58
Nitric oxide modulates pepsinogen secretion induced by calcium-mediated agonist in guinea pig gastric chief cells. 58
I peptidil leucotrieni regolano la secrezione di pepsinogeno e la mobilitazione del calcio nelle cellule principali isolate 58
Title: nitric oxide and lipoxins: role in inflammation and defence. 57
Nitric oxide inhibits hepatic stellate cell dependent tumor angiogenesis in primary and metastatic liver cancer 57
Enhanced activity of a hydrogen sulphide-releasing derivative of mesalamine (ATB-429) in a mouse model of colitis. 57
Epigenetic Modulation of Adhesion and Proliferation Pathways by Methionine Deficiency Attenuates Potential for Dissemination of Gastric Cancer Cells 57
Alkaline esophageal reflux- A misnomer 57
A beta-oxidation-resistant lipoxin A(4) analog treats hapten-induced colitis by attenuating inflammation and immune dysfunction 57
Prevention of nonsteroidal anti-inflammatory drug-induced ulcer: looking to the future. 56
Pathogenesis of non-steroidal anti-inflammatory drug gastropathy 56
Involvement of Cd44 Variant Isoforms In Hyaluronate Adhesion By Human Activated T-cells 56
3-oxa-lipoxin A4 analog treats colitis induced by Dss by attenuating inflammation and immunity. 56
NCX 1000, an NO-derivative of ursodeoxycholic acid protects against Th1-mediated liver damage in mice. 56
Gut microbiota role in irritable bowel syndrome: New therapeutic strategies 56
Cardiac safety and antitumoral activity of a new nitric oxide derivative of pegylated epirubicin in mice. 55
Current Advances In Therapeutic Applications of Nuclear Receptors 55
Discovery of sulfated sterols from marine invertebrates as a new class of marine naturalantagonists of farnesoid-X-receptor. 55
Totale 6.813
Salva come PNG Salva come JPEG
Categoria #
all - tutte 107.673
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 107.673
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.450 0 0 0 12 260 53 297 85 417 159 36 131
2020/20214.489 21 387 208 399 1.279 312 215 29 439 166 316 718
2021/20224.328 96 816 68 233 106 173 57 1.466 52 93 389 779
2022/20237.812 605 1.266 68 617 658 992 2 433 2.807 14 243 107
2023/20242.407 206 312 144 50 35 21 464 146 162 94 412 361
2024/20251.039 69 695 224 51 0 0 0 0 0 0 0 0
Totale 23.891